CEO buys one Series B Preferred share with special voting rights on share increase; annual meeting July 19

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

CEO Timothy Warbington purchased one Series B Preferred share for $100; it carries 100M votes on share increase proposal.
Series B Preferred votes proportionally with common stock on proposal to increase authorized common from 5M to 25M shares.
Series B automatically redeemed upon approval of share increase; not convertible into common.
Annual meeting of stockholders set for July 19, 2024; record date June 3, 2024.
Preliminary proxy statement filed with SEC regarding share increase and other proposals.

item 1.01 item 3.02 item 3.03 item 5.03 item 5.08 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.